Publication | Closed Access

Anthocyanins as a potential pharmacological agent to manage memory deficit, oxidative stress and alterations in ion pump activity induced by experimental sporadic dementia of Alzheimer's type

Alzheimer's DiseaseMedicineDementiaVascular DementiaNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeuroscienceNeurologyNeurodegenerationExperimental Sporadic DementiaPharmacologyNeurochemistryOxidative StressMemory Deficit